| Orciuolo E, Buda G, Pelosini M, et al.
Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma. [JOURNAL ARTICLE]
Br J Haematol 2009 Nov 16.
Full Citation | | George B, Kerridge I, Gilroy N, et al.
Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants. [JOURNAL ARTICLE]
Bone Marrow Transplant 2009 Nov 16.
Abstract | Full Citation | | Maeda A, Iwai K, Ishibashi T
Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate. [Journal Article]
Rinsho Ketsueki 2009 Aug; 50(8):658-62.
Abstract | Full Citation | Find Related Articles | | Kröger N, Shimoni A, Schilling G, et al.
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation. [JOURNAL ARTICLE]
Br J Haematol 2009 Nov 12.
Abstract | Full Citation | Find Related Articles | | Robak T, Jamroziak K, Robak P
Current and emerging treatments for chronic lymphocytic leukaemia. [Journal Article]
Drugs 2009; 69(17):2415-49.
Abstract | Full Citation | Find Related Articles | | Rogalińska M, Błoński JZ, Komina O, et al.
R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. [JOURNAL ARTICLE]
J Cell Biochem 2009 Nov 12.
Abstract | Full Citation | Find Related Articles | | Boland A, Bagust A, Hockenhull J, et al.
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma. [Journal Article, Research Support, Non-U.S. Gov't]
Health Technol Assess 2009 Sep.:41-8.
Abstract | Full Citation | Find Related Articles | | Nakamae H, Storer BE, Storb R, et al.
Low-dose Total Body Irradiation and Fludarabine Conditioning for HLA-Class I Mismatched Donor Stem Cell Transplantation and Immunological Recovery in Patients with Hematological Malignancies: A Multi-Center Trial. [JOURNAL ARTICLE]
Biol Blood Marrow Transplant 2009 Nov 6.
Abstract | Full Citation | | Sodani P, Isgro A, Gaziev J, et al.
Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia. [JOURNAL ARTICLE]
Blood 2009 Nov 6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bertz H, Spyridonidis A, Wäsch R, et al.
A novel GVHD-prophylaxis with low-dose alemtuzumab in allogeneic sibling or unrelated donor hematopoetic cell transplantation: the feasibility of deescalation. [Journal Article]
Biol Blood Marrow Transplant 2009 Dec; 15(12):1563-70.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
